ClinicalTrials.gg
Not yet recruitingNCT07309224EMPOWERUpdated Oct 2, 2026

Employing Peer Outreach and Whole Health in Recovery for Homeless-Experienced Veterans

An interventional study of Employing Peer Outreach and Whole Health in Recovery (EMPOWER) in Substance Use Disorder, Mental Health Disorder and Homelessness, sponsored by VA Office of Research and Development. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Health services research

Updated Oct 2, 2026Start date movedEligibility revisedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
278
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Homelessness is a national crisis in the United States, particularly in the veteran population. Due to multiple chronic conditions, homeless individuals frequently become hospitalized or are treated in emergency departments. Care engagement can mitigate this risk. Interventions grounded in evidence-based practices of peer support and whole health are effective for increasing care engagement. However, implementation of such interventions with high-acuity patients often requires strategies that are intensive and costly. This trial will evaluate the relative impacts and costs of using a high-intensity (vs. low-intensity) strategy to implement a peer-led, whole health intervention for homeless-experienced Veterans in permanent supportive housing.

Read the detailed description

Background: Homelessness is a national crisis in the United States, particularly in the Veteran population. Due to multiple chronic conditions, homeless individuals have elevated risk for acute care service use. Engagement in primary and specialty care can mitigate this risk. Interventions grounded in evidence-based practices of peer support, patient-centered care, and whole health are effective for increasing service engagement. However, implementation of such interventions with high-acuity patients often requires multi-component strategies that are intensive and costly. This study protocol describes a hybrid type 3 effectiveness-implementation trial of Employing Peer Outreach and Whole Health in Recovery (EMPOWER) with high-need, homeless-experienced Veterans in permanent supportive housing and will evaluate the impact and cost of a high-intensity (vs. low-intensity) strategy on implementation outcomes.

Methods: (Aim 1) At 7 sites in the Veterans Health Administration (VA), a mixed methods pre-implementation evaluation will identify determinants and their potential impact on uptake of the EMPOWER and inform modifications to the intervention and implementation strategies as needed. (Aim 2) A staircase cluster randomized design will evaluate the rollout of the implementation strategies, beginning with Audit and Feedback (low-intensity) and then switching to Facilitation (high-intensity) after 6 months. Facilitation is hypothesized to have a greater impact on the reach, effectiveness, adoption, implementation (fidelity), and maintenance of EMPOWER. (Aim 3) A budget impact analysis will estimate the average cost of implementing EMPOWER at future sites and comparative costs for implementing the low- and high-intensity strategies.

Anticipated Impact: This study will provide information on the relative impacts and relative costs of strategies aimed at implementing a peer-led, patient-centered, whole health intervention for homeless-experienced Veterans in permanent supportive housing. The findings will provide guidance to VA and other healthcare systems that serve the aging population of homeless-experienced Veterans.

02

Conditions studied

  • Substance Use Disorder
  • Mental Health Disorder
  • Homelessness

Keywords

  • Veterans
  • Homeless Persons
  • Peer Influence
  • Whole Person Health
  • Implementation Science
03

In context

Substance-Related Disorders

2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.

This study's planned enrollment of 278 is above the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,771 studies on the registry; 392 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 2, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eligible patients will be identified from VA's Homeless Registry "Hot Spot" reports, which use real-time data on acute care service utilization to identify high-need, housing-insecure patients.
  • These reports identify Veterans on the VA Homeless Registry (i.e., those who had received VA housing services in the past two years) who had >1 hospital admissions and/or >2 emergency department (ED) visits in the past quarter of the fiscal year.
  • From these reports, the investigators will identify patients at each implementation site who are

    • (a) currently enrolled in HUD-VASH
    • (b) have a mental health and/or substance use disorder (SUD) diagnosis

Exclusion criteria

Exclusion Criteria:

  • Not flagged on the VA's Homeless Registry Hot Spot Report
  • Not currently enrolled in HUD-VASH
  • Does not have a mental health and/or substance use disorder diagnosis
  • Is not a patient at a participating site of the implementation trial
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
278 participants (estimated)

Study arms

  • Active comparator
    Low-Intensity (LI)

    For the LI phase of a site's implementation, a light-touch strategy will be used to implement EMPOWER; specifically, Audit and Feedback. In Audit and Feedback, key stakeholders at sites receive summarized data about their performance relative to a standard or benchmark. Specifically, HUD-VASH peers and supervisors at each site will be emailed monthly automated reports on EMPOWER fidelity data from the EHR (e.g., % of HUD-VASH patients with a Personal Health Plan note) as well as aggregated data on treatment engagement via the Hot Spot dashboard (e.g., % of HUD-VASH Veterans with an SUD diagnosis who received SUD specialty care in the past month). The monthly reports will include tailored action item recommendations based on the local site's performance. Under the LI strategy, sites will not be provided interactive support to review these reports.

    Behavioral: Employing Peer Outreach and Whole Health in Recovery (EMPOWER)

  • Experimental
    High-Intensity (HI)

    For the HI phase of a site's implementation, a higher-intensity strategy will be used to implement EMPOWER; specifically, Facilitation. Facilitation is a collaborative strategy in which trained individuals work with organizations or teams to support the adoption, implementation, and sustainment of an evidence-based practice (EBP). It is a dynamic process that involves tailored guidance, problem-solving, technical assistance, and capacity-building activities to address specific barriers and leverage facilitators of change. To this end, external facilitators often collaborate with local champions to bring expertise regarding the implementation processes and have transferable knowledge in relevant clinical and behavior change models that inform the EBP's implementation.

    Behavioral: Employing Peer Outreach and Whole Health in Recovery (EMPOWER)

Interventions

  • BehavioralEmploying Peer Outreach and Whole Health in Recovery (EMPOWER)

    EMPOWER is a multicomponent intervention to facilitate homeless-experienced Veterans' (HEVs) care engagement: (DATA ANALYTICS) HUD-VASH case managers identify high-need, HUD-VASH Veterans on the Homeless Registry Hot Spot Report. Veterans' profiles are reviewed to learn about their chronic health conditions, housing status, acute care use, and engagement in supportive care. (PEER SUPPORT): HUD-VASH peers meet with identified Veterans for up to six months, averaging once-per week sessions for the first three months, with step-down in frequency as Veterans begin to engage in services and reach their goals. (WHOLE HEALTH): During sessions, peers use a Whole Health approach to collaboratively develop personal health goals that align with the Veteran's priorities and values-e.g, help Veterans completing a Personal Health Inventory and developing a Personal Health Plans. Provider communications: Peers communicate with a Veteran's care providers to share the Veteran's personal health goals.

    Also known as: EMPOWER

06

What researchers measure

Primary outcomes

  1. Reach

    Reach will be measured in terms of the number of patients who are willing to receive EMPOWER, out of all patients that are estimated to be eligible at potential sites.

    Time frame: 18 months

  2. Adoption

    Adoption will be measured in terms of the number of peers in HUD-VASH at sites that are trained in EMPOWER and initiate the intervention with eligible patients at their site.

    Time frame: 18 months

  3. Implementation

    Implementation will be measured in terms of rate of completion of peer encounters at the site level and rate of completion of the elements of EMPOWER (e.g., percentage of EMPOWER patients with a Personal Health Plan entered into the EHR; percentage of EMPOWER patients who were referred to a Whole Health service at the local facility). These rates will be measured via activity logs embedded in the EHR and electronic data capture logs to document type and length of encounters.

    Time frame: 18 months

  4. Maintenance

    Maintenance will be measured by the number of patients who are continuing to engage in EMPOWER and other VA services over the duration of the implementation phase (18 months).

    Time frame: 18 months

Secondary outcomes

  1. Effectiveness - Mental Health Outpatient Care

    Among patients who receive EMPOWER and have a mental health diagnosis, the number of outpatient visits for mental health care they receive after 6 months, as measured by VA administrative data (e.g., stop codes of outpatient encounters).

    Time frame: 6 months

  2. Effectiveness - Substance Use Disorder Outpatient Care

    Among patients who receive EMPOWER and have a diagnosis of a substance use disorder (SUD), the number of outpatient visits for SUD care they receive after 6 months, as measured by VA administrative data (e.g., stop codes of outpatient encounters).

    Time frame: 6 months

  3. Effectiveness - Primary Care

    Among patients who receive EMPOWER, the number of primary care visits they attend after 6 months, as measured by VA administrative data (e.g., stop codes of outpatient encounters).

    Time frame: 6 months

  4. Effectiveness - Whole Health care

    Among patients who receive EMPOWER, the number of outpatient visits for Whole Health-related care they receive after 6 months, as measured by VA administrative data (e.g., stop codes of outpatient encounters of health coaching and other complementary and integrative services).

    Time frame: 6 months

  5. Effectiveness - Hospitalizations

    Among patients who receive EMPOWER, the number of bed days of care for ambulatory-care sensitive conditions after 6 months, as measured by VA administrative data (e.g., Bedsection codes).

    Time frame: 6 months

  6. Effectiveness - Emergency department (ED) visits

    Among patients who receive EMPOWER, the number of visits to an emergency department after 6 months, as measured by VA administrative data (e.g., stop codes).

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Publications

  • Blonigen DM, Hyde J, Smith J, TorresTower S, Podchiyska T, Taylor TJ, Raciborski RA, Roy SG, Midboe AM. Employing Peer Outreach and Whole Health in Recovery (EMPOWER) for homeless-experienced veterans: protocol for a hybrid type 3 implementation trial. Implement Sci. 2026 Apr 8;21(1):35. doi: 10.1186/s13012-026-01499-y. PubMed 41952220 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Start date
Oct 1, 2026→Jan 1, 2027
Oct 2, 2026
Eligibility
2 inclusion criteria edited
What changed in the criteria
Inclusion criteria
  • EditedThese reports identify Veterans on the VA Homeless Registry (i.e., those who had received VA housing services in the past two years) who had >1 hospital admissions and/or >2 emergency department (ED) visits in the past quarter of the fiscal year.
  • Edited(b) have a mental health and/or substance use disorder (SUD) diagnosis
Oct 2, 2026
Secondary outcomes
1 edited
What changed in the outcomes
  • EditedEffectiveness - Emergency department (ED) visitsTime frame: 6 months
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Start date Oct 1, 2026→Jan 1, 2027
    Eligibility 2 inclusion criteria edited
    What changed in the criteria
    Inclusion criteria
    • EditedThese reports identify Veterans on the VA Homeless Registry (i.e., those who had received VA housing services in the past two years) who had >1 hospital admissions and/or >2 emergency department (ED) visits in the past quarter of the fiscal year.
    • Edited(b) have a mental health and/or substance use disorder (SUD) diagnosis
    Secondary outcomes 1 edited
    What changed in the outcomes
    • EditedEffectiveness - Emergency department (ED) visitsTime frame: 6 months
    + 3 other changes: verification date, description and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07309224
Responsible party
Sponsor
First posted
Dec 30, 2025
Start date
Jan 1, 2027 (estimated)
Primary completion
Jul 1, 2030 (estimated)
Completion
Sep 30, 2030 (estimated)
Last update
Oct 2, 2026

Study contacts

Daniel M Blonigen, PhD MA
Contact
Daniel.Blonigen@va.gov
(650) 493-5000 ext. 27828
Jennifer S Smith, MPH
Contact
jennifer.s.smith@va.gov
(650) 493-5000 ext. 27831
Daniel M. Blonigen, PhD MA
principal investigator · VA Palo Alto Health Care System, Palo Alto, CA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion